nach oben

Erschienen in:

01.12.2023 | Review

Radiomic applications in upper gastrointestinal cancer surgery

verfasst von: Joseph P. Doyle, Pranav H. Patel, Nikoletta Petrou, Joshua Shur, Matthew Orton, Sacheen Kumar, Ricky H. Bhogal

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Cross-sectional imaging plays an integral role in the management of upper gastrointestinal (UGI) cancer, from initial diagnosis and staging to determining appropriate treatment strategies. Subjective imaging interpretation has known limitations. The field of radiomics has evolved to extract quantitative data from medical imaging and relate these to biological processes. The key concept behind radiomics is that the high-throughput analysis of quantitative imaging features can provide predictive or prognostic information, with the goal of providing individualised care.

Objective

Radiomic studies have shown promising utility in upper gastrointestinal oncology, highlighting a potential role in determining stage of disease and degree of tumour differentiation and predicting recurrence-free survival. This narrative review aims to provide an insight into the concepts underpinning radiomics, as well as its potential applications for guiding treatment and surgical decision-making in upper gastrointestinal malignancy.

Conclusion

Outcomes from studies to date have been promising; however, further standardisation and collaboration are required. Large prospective studies with external validation and evaluation of radiomic integration into clinical pathways are needed. Future research should now focus on translating the promising utility of radiomics into meaningful patient outcomes.

Stanzione A, Verde F, Romeo V, Boccadifuoco F, Mainenti PP, Maurea S (2021) Radiomics and machine learning applications in rectal cancer: current update and future perspectives. WJG 27(32):5306–5321PubMedPubMedCentralCrossRef

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RGPM, Granton P et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446PubMedPubMedCentralCrossRef

Alderson PO, Summers RM (2020) The evolving status of radiomics. JNCI: J Natl Cancer Inst 112(9):869–70PubMedPubMedCentralCrossRef

Yip SSF, Aerts HJWL (2016) Applications and limitations of radiomics. Phys Med Biol 61(13):R150–R166PubMedPubMedCentralCrossRef

Wang Y, Jin ZY (2019) Radiomics approaches in gastric cancer: a frontier in clinical decision making. Chin Med J 132(16):1983–1989PubMedPubMedCentralCrossRef

Shur JD, Doran SJ, Kumar S, apDafydd D, Downey K, O’Connor JPB et al (2021) Radiomics in oncology: a practical guide. RadioGraphics 41(6):1717–32PubMedCrossRef

Mayerhoefer ME, Materka A, Langs G, Häggström I, Szczypiński P, Gibbs P et al (2020) Introduction to radiomics. J Nucl Med 61(4):488–495PubMedPubMedCentralCrossRef

Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG et al (2018) Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2(1):36PubMedPubMedCentralCrossRef

van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B (2020) Radiomics in medical imaging—“how-to” guide and critical reflection. Insights Imaging 11(1):91PubMedPubMedCentralCrossRef

10.

Shaikh FA, Kolowitz BJ, Awan O, Aerts HJ, von Reden A, Halabi S et al (2017) Technical challenges in the clinical application of radiomics. JCO Clin Cancer Inf 1:1–8

11.

Mu W, Schabath MB, Gillies RJ (2022) Images are data: challenges and opportunities in the clinical translation of radiomics. Can Res 82(11):2066–2068CrossRef

12.

Avanzo M, Stancanello J, El Naqa I (2017) Beyond imaging: the promise of radiomics. Physica Med 38:122–139CrossRef

13.

Alderson PO (2020) The quest for generalizability in radiomics. Radiology: Artif Intell 2(3):e200068

14.

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V et al (2017) Computational radiomics system to decode the radiographic phenotype. Can Res 77(21):e104–e107CrossRef

15.

Bibault JE, Xing L, Giraud P, El Ayachy R, Giraud N, Decazes P et al (2020) Radiomics: a primer for the radiation oncologist. Cancer/Radiothérapie 24(5):403–410PubMedCrossRef

16.

Bodalal Z, Trebeschi S, Nguyen-Kim TDL, Schats W, Beets-Tan R (2019) Radiogenomics: bridging imaging and genomics. Abdom Radiol 44(6):1960–1984CrossRef

17.

Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26(6):565–574PubMedPubMedCentralCrossRef

18.

Wu L, Wang C, Tan X, Cheng Z, Zhao K, Yan L et al (2018) Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer. Chin J Cancer Res 30(4):396–405PubMedPubMedCentralCrossRef

19.

Kawahara D, Murakami Y, Tani S, Nagata Y (2021) A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning. BJR 94(1124):20210525PubMedPubMedCentralCrossRef

20.

Gao X, Ma T, Cui J, Zhang Y, Wang L, Li H et al (2021) A CT-based radiomics model for prediction of lymph node metastasis in early stage gastric cancer. Acad Radiol 28(6):e155–e164PubMedCrossRef

21.

Wang Y, Liu W, Yu Y, Liu JJ, Xue HD, Qi YF et al (2020) CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer. Eur Radiol. 30(2):976–86PubMedCrossRef

22.

Sun Z, Jiang Y, Chen C, Zheng H, Huang W, Xu B et al (2021) Radiomics signature based on computed tomography images for the preoperative prediction of lymph node metastasis at individual stations in gastric cancer: a multicenter study. Radiother Oncol 165:179–190PubMedCrossRef

23.

Dong D, Fang MJ, Tang L, Shan XH, Gao JB, Giganti F et al (2020) Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol 31(7):912–920PubMedCrossRef

24.

Zhao B, Zhu HT, Li XT, Shi YJ, Cao K, Sun YS (2021) Predicting lymph node metastasis using computed tomography radiomics analysis in patients with resectable esophageal squamous cell carcinoma. J Comput Assist Tomogr 45(2):323–329PubMedCrossRef

25.

Shen C, Liu Z, Wang Z, Guo J, Zhang H, Wang Y et al (2018) Building CT radiomics based nomogram for preoperative esophageal cancer patients lymph node metastasis prediction. Translational Oncology 11(3):815–824PubMedPubMedCentralCrossRef

26.

Chen Y, Xi W, Yao W, Wang L, Xu Z, Wels M et al (2021) Dual-energy computed tomography-based radiomics to predict peritoneal metastasis in gastric cancer. Front Oncol 14(11):659981CrossRef

27.

Xue B, Jiang J, Chen L, Wu S, Zheng X, Zheng X et al (2021) Development and validation of a radiomics model based on 18F-FDG PET of primary gastric cancer for predicting peritoneal metastasis. Front Oncol 26(11):740111CrossRef

28.

Peng H, Xue T, Chen Q, Li M, Ge Y, Feng F (2022) Computed tomography-based radiomics nomogram for predicting the postoperative prognosis of esophageal squamous cell carcinoma: a multicenter study. Acad Radiol S1076-6332(22)00070-8

29.

Tang S, Ou J, Wu YP, Li R, Chen TW, Zhang XM (2021) Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy: a case-control study. Medicine 100(27):e26557PubMedPubMedCentralCrossRef

30.

Tang S, Ou J, Liu J, Wu YP, Wu CQ, Chen TW et al (2021) Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy. Cancer Imaging 21(1):38PubMedPubMedCentralCrossRef

31.

Kong J, Zhu S, Shi G, Liu Z, Zhang J, Ren J (2021) Prediction of locoregional recurrence-free survival of oesophageal squamous cell carcinoma after chemoradiotherapy based on an enhanced CT-based radiomics model. Front Oncol 24(11):739933CrossRef

32.

Luo HS, Chen YY, Huang WZ, Wu SX, Huang SF, Xu HY et al (2021) Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiat Oncol 16(1):201PubMedPubMedCentralCrossRef

33.

Deantonio L, Garo ML, Paone G, Valli MC, Cappio S, La Regina D et al (2022) 18F-FDG PET radiomics as predictor of treatment response in oesophageal cancer: a systematic review and meta-analysis. Front Oncol 15(12):861638CrossRef

34.

van Rossum PSN, Fried DV, Zhang L, Hofstetter WL, van Vulpen M, Meijer GJ et al (2016) The incremental value of subjective and quantitative assessment of ¹⁸ F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer. J Nucl Med 57(5):691–700PubMedCrossRef

35.

Yip SSF, Coroller TP, Sanford NN, Mamon H, Aerts HJWL, Berbeco RI (2016) Relationship between the temporal changes in positron-emission-tomography-imaging-based textural features and pathologic response and survival in esophageal cancer patients. Front Oncol 6:72

36.

Eyck BM, van der Wilk BJ, Lagarde SM, Wijnhoven BPL, Valkema R, Spaander MCW, Nuyttens JJME, van der Gaast A, van Lanschot JJB (2018) Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. Best Pract Res Clin Gastroenterol 36–37:37–44PubMedCrossRef

37.

Beukinga RJ, Hulshoff JB, van Dijk LV, Muijs CT, Burgerhof JGM, Kats-Ugurlu G et al (2017) Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pretreatment ¹⁸ F-FDG PET/CT imaging. J Nucl Med 58(5):723–729PubMedCrossRef

38.

Hirata A, Hayano K, Ohira G, Imanishi S, Hanaoka T, Murakami K et al (2020) Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy. Am J Surg 219(6):1024–1029PubMedCrossRef

39.

Yang Z, He B, Zhuang X, Gao X, Wang D, Li M et al (2019) CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Radiat Res 60(4):538–545PubMedPubMedCentralCrossRef

40.

Rishi A, Zhang GG, Yuan Z, Sim AJ, Song EY, Moros EG et al (2021) Pretreatment CT and ¹⁸ F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer. J Med Imag Rad Onc 65(1):102–111CrossRef

41.

Hu Y, Xie C, Yang H, Ho JWK, Wen J, Han L et al (2020) Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA Netw Open 3(9):e2015927PubMedPubMedCentralCrossRef

42.

Murakami Y, Kawahara D, Tani S, Kubo K, Katsuta T, Imano N et al (2021) Predicting the local response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy by radiomics with a machine learning method using 18F-FDG PET images. Diagnostics 11(6):1049PubMedPubMedCentralCrossRef

43.

Zhu WS, Shi SY, Yang ZH, Song C, Shen J (2020) Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure. WJG 26(11):1208–1220PubMedPubMedCentralCrossRef

44.

Chen Y, Liu Z, Mo Y, Li B, Zhou Q, Peng S et al (2021) Prediction of post-hepatectomy liver failure in patients with hepatocellular carcinoma based on radiomics using Gd-EOB-DTPA-enhanced MRI: the liver failure model. Front Oncol 10(11):605296CrossRef

45.

Søreide JA, Deshpande R (2021) Post hepatectomy liver failure (PHLF) – recent advances in prevention and clinical management. Eur J Surg Oncol 47(2):216–224PubMedCrossRef

46.

Cai W, He B, Hu M, Zhang W, Xiao D, Yu H et al (2019) A radiomics-based nomogram for the preoperative prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma. Surg Oncol 28:78–85PubMedCrossRef

47.

Xiang F, Liang X, Yang L, Liu X, Yan S (2021) CT radiomics nomogram for the preoperative prediction of severe post-hepatectomy liver failure in patients with huge (≥ 10 cm) hepatocellular carcinoma. World J Surg Onc 19(1):344CrossRef

48.

Hanafy AS (2021) Prediction and prevention of post-hepatectomy liver failure: where do we stand? J Clin Transl Hepatol 000(000):000–000CrossRef

49.

Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG et al (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105(8):946–958PubMedCrossRef

50.

Maeda S, Moore AM, Yohanathan L, Hata T, Truty MJ, Smoot RL et al (2020) Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy. Surgery 167(5):803–811PubMedCrossRef

51.

Fukuda Y, Yamada D, Eguchi H, Hata T, Iwagami Y, Noda T et al (2017) CT density in the pancreas is a promising imaging predictor for pancreatic ductal adenocarcinoma. Ann Surg Oncol 24(9):2762–2769PubMedCrossRef

52.

Weyhe D, Obonyo D, Uslar VN, Stricker I, Tannapfel A (2021) Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: making a case for standardized reporting of the resection margin using certified cancer center data. Wellner U, editor. PLoS ONE 16(3):e0248633

53.

Ocaña J, Sanjuanbenito A, García A, Molina JM, Lisa E, Mendía E et al (2020) Relevance of positive resection margins in ductal pancreatic adenocarcinoma and prognostic factors. Cirugía Española (English Edition) 98(2):85–91CrossRef

54.

Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB 11(1):18–24PubMedPubMedCentralCrossRef

55.

Liu KL, Wu T, Chen PT, Tsai YM, Roth H, Wu MS et al (2020) Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation. Lancet Digital Health 2(6):e303–e313PubMedCrossRef

56.

Cassinotto C, Dohan A, Zogopoulos G, Chiche L, Laurent C, Sa-Cunha A et al (2017) Pancreatic adenocarcinoma: a simple CT score for predicting margin-positive resection in patients with resectable disease. Eur J Radiol 95:33–38PubMedCrossRef

57.

Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-del Castillo C, Hackert T et al (2018) International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 18(1):2–11PubMedCrossRef

58.

Kobi M, Veillette G, Narurkar R, Sadowsky D, Paroder V, Shilagani C et al (2020) Imaging and management of pancreatic cancer. Sem Ultrasound CT MRI 41(2):139–151CrossRef

59.

Lopez NE (2014) Borderline resectable pancreatic cancer: definitions and management. WJG 20(31):10740PubMedPubMedCentralCrossRef

60.

Bian Y, Jiang H, Ma C, Cao K, Fang X, Li J et al (2020) Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer. Abdom Radiol 45(3):759–773CrossRef

61.

Rigiroli F, Hoye J, Lerebours R, Lafata KJ, Li C, Meyer M et al (2021) CT radiomic features of superior mesenteric artery involvement in pancreatic ductal adenocarcinoma: a pilot study. Radiology 7:210699

62.

Lin Z, Tang B, Cai J, Wang X, Li C, Tian X, Yang Y, Wang X (2021) Preoperative prediction of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy. Eur J Radiol 139:109693PubMedCrossRef

63.

Zhang W, Cai W, He B, Xiang N, Fang C, Jia F (2018) A radiomics-based formula for the preoperative prediction of postoperative pancreatic fistula in patients with pancreaticoduodenectomy. Cancer Manag Res 28(10):6469–6478CrossRef

64.

Skawran SM, Kambakamba P, Baessler B, von Spiczak J, Kupka M, Müller PC, Moeckli B, Linecker M, Petrowsky H, Reiner CS (2021) Can magnetic resonance imaging radiomics of the pancreas predict postoperative pancreatic fistula? Eur J Radiol 140:109733PubMedCrossRef

65.

Lee CH, Yoon HJ (2017) Medical big data: promise and challenges. Kidney Res Clin Pract 36(1):3–11PubMedPubMedCentralCrossRef

66.

de la Pinta C (2021) Radiomics in pancreatic cancer for oncologist: present and future. Hepatobiliary Pancreat Dis Int 21(4):356–361

67.

Chetan MR, Gleeson FV (2021) Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol 31(2):1049–1058PubMedCrossRef

68.

Park JE, Kim D, Kim HS, Park SY, Kim JY, Cho SJ, Shin JH, Kim JH (2020) Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement. Eur Radiol 30(1):523–536PubMedCrossRef

69.

Lambin P. Radiomics quality score - RQS. Available from: https://www.radiomics.world (Accessed: May 2023)

70.

Fanciullo C, Gitto S, Carlicchi E, Albano D, Messina C, Sconfienza LM (2022) Radiomics of musculoskeletal sarcomas: a narrative review. J Imaging 8(2):45PubMedPubMedCentralCrossRef

71.

Chen B, Yang L, Zhang R, Luo W, Li W (2020) Radiomics: an overview in lung cancer management—a narrative review. Ann Transl Med 8(18):1191–1191PubMedPubMedCentralCrossRef

Titel: Radiomic applications in upper gastrointestinal cancer surgery
verfasst von: Joseph P. Doyle
Pranav H. Patel
Nikoletta Petrou
Joshua Shur
Matthew Orton
Sacheen Kumar
Ricky H. Bhogal
Publikationsdatum: 01.12.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 1/2023
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-023-02951-z

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Radiomic applications in upper gastrointestinal cancer surgery